Parallax Volatility Advisers’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Parallax Volatility Advisers’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-249,200	Closed	-$9.8M	–	2738
2023 Q2	$9.8M	Buy	249,200 +143,300	+135%	+$5.06M	0.02%	540
2023 Q1	$2.58M	Buy	+105,900	New	+$2.32M	0.01%	1147
2022 Q4	–	Sell	-40,000	Closed	-$718K	–	3412
2022 Q3	$718K	Buy	+40,000	New	+$525K	﹤0.01%	1859
2022 Q2	–	Sell	-56,000	Closed	-$942K	–	3428
2022 Q1	$942K	Buy	+56,000	New	+$828K	﹤0.01%	1680
2021 Q4	–	Sell	-10,000	Closed	-$162K	–	2439
2021 Q3	$162K	Buy	+10,000	New	+$109K	﹤0.01%	1730
2017 Q1	–	Sell	-27,500	Closed	-$133K	–	4886
2016 Q4	$133K	Buy	27,500 +25,000	+1,000%	+$742K	﹤0.01%	2080
2016 Q3	$115K	Buy	+2,500	New	+$141K	﹤0.01%	2068

Parallax Volatility Advisers's ISEE Position: Q2 2023 in Review

Parallax Volatility Advisers sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 48 shares — an estimated $1.69K sold.

Parallax Volatility Advisers first reported a position in ISEE in Q2 2016 and held it in 5 quarters. The position peaked at $982K in Q2 2022. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

Parallax Volatility Advisers reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Parallax Volatility Advisers sold 48 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $1.69K.
Parallax Volatility Advisers first reported a position in IVERIC bio, Inc. Common Stock in Q2 2016 and held it in 5 quarters.
Parallax Volatility Advisers's IVERIC bio, Inc. Common Stock position peaked at $982K in Q2 2022.
256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Parallax Volatility Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.